Literature DB >> 17690886

Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report.

Paola Caramaschi1, Alessandro Volpe, Antonio Carletto, Lisa Maria Bambara, Domenico Biasi.   

Abstract

The authors describe a young man suffering from systemic sclerosis who showed a dramatic progression of skin involvement after the appearance of anti-Scl70 antibody.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17690886     DOI： 10.1007/s00296-007-0434-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  9 in total

1.  Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.

Authors:  Paul Q Hu; Noreen Fertig; Thomas A Medsger; Timothy M Wright
Journal:  Arthritis Rheum       Date:  2003-05

2.  Autoantibodies in systemic sclerosis.

Authors:  Virginia D Steen
Journal:  Semin Arthritis Rheum       Date:  2005-08       Impact factor: 5.532

3.  DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.

Authors:  Jill Hénault; Geneviève Robitaille; Jean-Luc Senécal; Yves Raymond
Journal:  Arthritis Rheum       Date:  2006-03

4.  Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?

Authors:  E Diot; B Giraudeau; P Diot; D Degenne; L Ritz; J L Guilmot; E Lemarié
Journal:  Chest       Date:  1999-09       Impact factor: 9.410

5.  Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.

Authors:  S Jacobsen; S Ullman; G Q Shen; A Wiik; P Halberg
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

6.  Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.

Authors:  U A Walker; A Tyndall; L Czirják; C Denton; D Farge-Bancel; O Kowal-Bielecka; U Müller-Ladner; C Bocelli-Tyndall; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2007-01-18       Impact factor: 19.103

Review 7.  Systemic sclerosis: current views of its pathogenesis.

Authors:  Chris T Derk; Sergio A Jimenez
Journal:  Autoimmun Rev       Date:  2003-06       Impact factor: 9.754

8.  Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.

Authors:  Jill Hénault; Mélanie Tremblay; Isabelle Clément; Yves Raymond; Jean-Luc Senécal
Journal:  Arthritis Rheum       Date:  2004-10

9.  Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.

Authors:  M Cutolo; C Pizzorni; M Tuccio; A Burroni; C Craviotto; M Basso; B Seriolo; A Sulli
Journal:  Rheumatology (Oxford)       Date:  2004-03-16       Impact factor: 7.580
  9 in total
  1 in total

1.  Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis.

Authors:  Alessandro Volpe; Orazio Ruzzenente; Paola Caramaschi; Sara Pieropan; Ilaria Tinazzi; Antonio Carletto; Lisa Maria Bambara; Domenico Biasi
Journal:  Rheumatol Int       Date:  2009-02-05       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.